Tact.ai is a mobile-based integrated solution provider that focuses on life science organizations (pharmaceutical, medical device, and BioTech firms) to support the customer engagement process for field sales teams. The AI-powered Tact assistant features omnichannel support (phone, email, video, chat, and self-service), lead management, a customer data platform (CDP), conversational AI, collaborative workspaces, automated workflows, forecasting, analytics, and reporting. The platform is also integrated with customer relationship management (CRM) platforms, personalized productivity tools such as email, calendar, next-best engines, and third-party data integrations. As of June 2022, the platform served Fortune 500 sales organizations, including Honeywell and Cisco.
The firm claimed that its customization functionality is up to 80% automated, giving users a personalized experience. Additionally, the company claimed to offer enterprise-grade security for user data by providing a BYOK (Bring Your Own Key) Encrypted Single-Tenant Mode. This gives users control over their data, unlike other SaaS companies that store customer data in a multi-tenant database.
Key customers and partnerships
In March 2021, the company partnered with BASE Life Science, a specialized management consultancy firm, to support life science brands in improving engagement with healthcare professionals. This marks the company’s first partnership in Europe.
Funding and financials
In March 2022, Tact.ai announced that it had raised an undisclosed amount of funding from Hikma Ventures. The round followed the USD 33 million it raised in September 2021 with participation from Novartis (dRx Capital), Lilly, and McKesson Ventures. The company planned to use the most recent funds for platform development and expansion purposes.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.